JP2004530731A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004530731A5 JP2004530731A5 JP2003510034A JP2003510034A JP2004530731A5 JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5 JP 2003510034 A JP2003510034 A JP 2003510034A JP 2003510034 A JP2003510034 A JP 2003510034A JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134775A DE10134775A1 (en) | 2001-07-06 | 2001-07-06 | 1-alkyl-2.aryl-benzimidazole derivatives, their use for the manufacture of medicaments and pharmaceutical preparations containing these derivatives |
| PCT/EP2002/007597 WO2003004023A1 (en) | 2001-07-06 | 2002-07-06 | 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004530731A JP2004530731A (en) | 2004-10-07 |
| JP2004530731A5 true JP2004530731A5 (en) | 2009-10-01 |
Family
ID=7692119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510034A Pending JP2004530731A (en) | 2001-07-06 | 2002-07-06 | 1-Alkyl-2-aryl-benzimidazole derivatives, their use for the preparation of pharmaceutical preparations, and pharmaceutical preparations containing these derivatives |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1404321A1 (en) |
| JP (1) | JP2004530731A (en) |
| DE (1) | DE10134775A1 (en) |
| WO (1) | WO2003004023A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10207843A1 (en) * | 2002-02-15 | 2003-09-04 | Schering Ag | Microlia inhibitors for interruption of interleukin 12 and IFN-gamma mediated immune responses |
| ES2497116T3 (en) * | 2002-08-19 | 2014-09-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as antimicrobial agents |
| US7582761B2 (en) | 2002-10-17 | 2009-09-01 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| JP5095216B2 (en) | 2003-11-14 | 2012-12-12 | ローラス セラピューティクス インコーポレーテッド | Arylimidazoles and their use as anticancer agents |
| DE102004026590A1 (en) * | 2004-06-01 | 2006-01-12 | Siemens Ag | Assistance system for motor vehicles |
| WO2006126177A2 (en) | 2005-05-25 | 2006-11-30 | Genesense Technologies Inc. | 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| WO2010036908A1 (en) * | 2008-09-26 | 2010-04-01 | Eisai R & D Management Co., Ltd. | Use of benzoxazole compounds in the treatment of malaria |
| US8354400B2 (en) | 2008-09-26 | 2013-01-15 | Eisai R&D Co., Ltd. | Benzoxazole compounds and methods of use |
| WO2011045415A2 (en) * | 2009-10-15 | 2011-04-21 | Guerbet | New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| EP2976342A4 (en) | 2013-03-20 | 2016-08-10 | Aptose Biosciences Inc | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| EP3650023A1 (en) | 2013-10-04 | 2020-05-13 | Aptose Biosciences Inc. | Compositions for treating cancers |
| EP3741747A1 (en) * | 2015-12-15 | 2020-11-25 | The Board of Trustees of the Leland Stanford Junior University | Method for preventing and/or treating aging-associated cognitive impairment |
| US11149047B2 (en) | 2017-10-30 | 2021-10-19 | Aptose Biosciences, Inc. | Aryl imidazoles for treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330959A1 (en) * | 1993-09-09 | 1995-03-16 | Schering Ag | New benzimidazole derivatives, processes for their preparation and their pharmaceutical use |
| US5552426A (en) * | 1994-04-29 | 1996-09-03 | Eli Lilly And Company | Methods for treating a physiological disorder associated with β-amyloid peptide |
| MXPA02005742A (en) * | 2000-01-14 | 2002-09-18 | Schering Ag | 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation. |
-
2001
- 2001-07-06 DE DE10134775A patent/DE10134775A1/en not_active Ceased
-
2002
- 2002-07-06 WO PCT/EP2002/007597 patent/WO2003004023A1/en active Application Filing
- 2002-07-06 EP EP02762333A patent/EP1404321A1/en not_active Withdrawn
- 2002-07-06 JP JP2003510034A patent/JP2004530731A/en active Pending